The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies.
PropertyValue
has major subject area list Adjuvants, Immunologic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Differentiation; CD47 Antigen; Neoplasms; Receptors, Immunologic
has minor subject area list Animals; Antibodies, Monoclonal, Murine-Derived; Cell Line, Tumor; Directed Molecular Evolution; Humans; Immunotherapy; Macrophage Activation; Mice; Phagocytosis; Rituximab
information resource reference Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013 Jul 05; 341(6141):88-91.
label Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies.
Search Criteria
  • Antibodies